Abstract
Personalized Medicine in Psychiatry (PMP) is the science of the systematic use of individual characteristics across four domains (life story, environmental factors, psychopathology assessment, and translational neuroscience findings [e.g., brain imaging, genomics, pharmacogenomics, biomarkers, endophenotypes, or any newly developed technique or blood test]) to guide the clinician toward a person-centered diagnosis, person-centered prognosis, and person-centered therapeutics (e.g., personalized selection and personalized dosing of medications). The clinician’s ultimate goal is to improve the outcome of the disease, and eventually to prevent the disease. Each of the SCIP’s 30 screening items and 200 psychopathology items has a unique PMP code. Chapter 11 demonstrates how to use the SCIP as a new PMP assessment tool. Case demonstrations are also be shown.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wium-Andersen, I. K., Vinberg, M., Kessing, L. V., & McIntyre, R. S. (2017). Personalized medicine in psychiatry. Nordic Journal of Psychiatry, 71, 12–19.
Domschke, K., Muller, D. J., & Serretti, A. (2015). Personalized therapies in psychiatry: Promises, pitfalls and perspectives. Journal of Neural Transmission, 122, 1–3.
Hong, D. S. (2014). Here/in this issue and there/abstract thinking: Personalized psychiatry: Are we almost there? Journal of the American Academy of Child and Adolescent Psychiatry, 53, 263–264.
Kessler, R. C., McLaughlin, K. A., Green, J. G., Gruber, M. J., Sampson, N. A., Zaslavsky, A. M., Aguilar-Gaxiola, S., Alhamzawi, A. O., Alonso, J., Angermeyer, M., Benjet, C., Bromet, E., Chatterji, S., de Girolamo, G., Demyttenaere, K., Fayyad, J., Florescu, S., Gal, G., Gureje, O., … Williams, D. R. (2010). Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys. The British Journal of Psychiatry: The Journal of Mental Science, 197, 378–385.
Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., Read, J., van Os, J., & Bentall, R. P. (2012). Childhood adversities increase the risk of psychosis: A meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophrenia Bulletin, 38, 661–671.
Sonnby, K., Aslund, C., Leppert, J., & Nilsson, K. W. (2011). Symptoms of ADHD and depression in a large adolescent population: Co-occurring symptoms and associations to experiences of sexual abuse. Nordic Journal of Psychiatry, 65, 315–322.
Weber, K., Rockstroh, B., Borgelt, J., Awiszus, B., Popov, T., Hoffmann, K., Schonauer, K., Watzl, H., & Propster, K. (2008). Stress load during childhood affects psychopathology in psychiatric patients. BMC Psychiatry, 8, 63.
Peterson, B. S. (2020). Editorial: Biomarkers in precision medicine for mental illnesses. Journal of Child Psychology and Psychiatry, 61, 1279–1281.
Manchia, M., Pisanu, C., Squassina, A., & Carpiniello, B. (2020). Challenges and future prospects of precision medicine in psychiatry. Pharmacogenomics and Personalized Medicine, 13, 127–140.
Krueger, R. F., & Bezdjian, S. (2009). Enhancing research and treatment of mental disorders with dimensional concepts: Toward DSM-V and ICD-11. World Psychiatry, 8, 3–6.
Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clinical Pharmacology & Therapeutics, 69, 89–95.
Keshavan, M. S. (2013). Classification of psychotic disorders: Need to move toward a neuroscience-informed nosology. Asian Journal of Psychiatry, 6, 191–192.
Keshavan, M. S. (2013). Nosology of psychoses in DSM-5: Inches ahead but miles to go. Schizophrenia Research, 150, 40–41.
Kendler, K. S. (2009). An historical framework for psychiatric nosology. Psychological Medicine, 39, 1935–1941.
National Research Council. (2011). Toward precision medicine: Building a knowledge network for biomedical research and a new taxonomy of disease. National Research Council.
Cuthbert, B. N. (2014). The RDoC framework: Facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry, 13, 28–35.
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010). Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. The American Journal of Psychiatry, 167, 748–751.
Keshavan, M. S., Tandon, R., & Nasrallah, H. A. (2013). Renaming schizophrenia: Keeping up with the facts. Schizophrenia Research, 148, 1–2.
Stoyanov, D. S. (2017). Key developments in translational neuroscience: An update. Balkan Medical Journal, 34, 485–486.
Aragona, M. (2017). The impact of translational neuroscience on revisiting psychiatric diagnosis: State of the art and conceptual analysis. Balkan Medical Journal, 34, 487–492.
Lilienfeld, S. O. (2014). The Research Domain Criteria (RDoC): An analysis of methodological and conceptual challenges. Behaviour Research and Therapy, 62, 129–139.
Carroll, B. J. (2015). Clinical science and biomarkers: Against RDoC. Acta Psychiatrica Scandinavica, 132, 423–424.
Chang, H. (2004). Inventing temperature: Measurement and scientific progress. Oxford University Press.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Aboraya, A.S. (2022). The Standard for Clinicians’ Interview in Psychiatry (SCIP) as an Assessment Tool for Personalized Medicine in Psychiatry. In: Manual for the Standard for Clinicians’ Interview in Psychiatry (SCIP). Advances in Mental Health and Addiction. Springer, Cham. https://doi.org/10.1007/978-3-030-94930-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-94930-3_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-94929-7
Online ISBN: 978-3-030-94930-3
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)